AVGO
Broadcom Inc.
AVGO has the edge over STX overall, supported by stronger valuation.
STX
Seagate Technology Holdings plc
STX has slightly lower modeled downside risk, despite its lower overall score.
AVGO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AVGO's revenue, profitability, cash flow and balance sheet are all currently strong.
STX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
STX's revenue, profitability, cash flow and balance sheet are all currently strong.
AVGO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $364 | — |
| Cheap | 27x | $211 | -42% |
| Current | 46x | $364 | — |
| Fair | 49x | $384 | +5.3% |
| Expensive | 86x | $671 | +84% |
Historical ranges are pointers, not guarantees.
AVGO has the edge over STX in the historical PE scenario, which offers more potential upside but is not a forecast.
STX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.9x | $188 | -65% |
| Forward | 12x | $545 | — |
| Fair | 17x | $318 | -42% |
| Current | 29x | $545 | — |
| Expensive | 43x | $823 | +51% |
Historical ranges are pointers, not guarantees.
STX's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its cheap range.
AVGO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for AVGO, with profitability holding steady.
STX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
STX has the edge over AVGO on the outlook, with more favorable profitability expectations.
AVGO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $19.23 | +145% |
| Q3 2026 | $7.84 | +100% |
| Q2 2026 | $6.01 | +125% |
| Q1 2026 | $5.13 | +145% |
| Q4 2025 | $4.77 | +288% |
| Q3 2025 | $3.92 | +241% |
| Q2 2025 | $2.67 | +15% |
| Q1 2025 | $2.09 | -23% |
| Q4 2024 | $1.23 | -63% |
AVGO earned $7.84 per share over the past year, up 100% from the year before.
STX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.99 | +147% |
| Q3 2026 | $19.06 | +145% |
| Q2 2026 | $13.90 | +105% |
| Q1 2026 | $10.54 | +51% |
| Q4 2025 | $8.84 | +60% |
| Q3 2025 | $7.79 | +101% |
| Q2 2025 | $6.77 | +328% |
| Q1 2025 | $6.96 | +$8.26 |
| Q4 2024 | $5.51 | +$9.02 |
STX has the edge over AVGO on earnings, with more consistent year-over-year improvement.
AVGO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $29.6B | +86% |
| Q2 2026 | $22.2B | +48% |
| Q1 2026 | $19.3B | +29% |
| Q4 2025 | $18B | +28% |
| Q3 2025 | $16B | +22% |
| Q2 2025 | $15B | +20% |
| Q1 2025 | $14.9B | +25% |
| Q4 2024 | $14.1B | +51% |
AVGO's revenue has grown year over year every quarter since late 2020: $29.6B last quarter, up 86% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 54% | +17 points |
| Q2 2026 | 49% | +9.8 points |
| Q1 2026 | 44% | +2.4 points |
| Q4 2025 | 42% | +8.8 points |
| Q3 2025 | 37% | +7.9 points |
| Q2 2025 | 39% | +15 points |
| Q1 2025 | 42% | +25 points |
| Q4 2024 | 33% | -13 points |
AVGO has the edge over STX on profitability, with a higher operating margin.
STX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.2B | +61% |
| Q2 2026 | $3.6B | +48% |
| Q1 2026 | $3.1B | +44% |
| Q4 2025 | $2.8B | +22% |
| Q3 2025 | $2.6B | +21% |
| Q2 2025 | $2.4B | +30% |
| Q1 2025 | $2.2B | +31% |
| Q4 2024 | $2.3B | +50% |
STX has the edge over AVGO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 49% | +22 points |
| Q2 2026 | 43% | +20 points |
| Q1 2026 | 32% | +12 points |
| Q4 2025 | 30% | +8.9 points |
| Q3 2025 | 26% | +7.8 points |
| Q2 2025 | 23% | +6.6 points |
| Q1 2025 | 20% | +11 points |
| Q4 2024 | 21% | +13 points |
STX's operating margin was 49% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2020.
AVGO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.7B | +95% |
| Q2 2026 | $10.3B | +60% |
| Q1 2026 | $8B | +33% |
| Q4 2025 | $7.5B | +36% |
| Q3 2025 | $7B | +47% |
| Q2 2025 | $6.4B | +44% |
| Q1 2025 | $6B | +28% |
| Q4 2024 | $5.5B | +16% |
AVGO's free cash flow has been positive every quarter for seven years: $39.4B over the past year, up 58% from the year before.
STX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +246% |
| Q2 2026 | $1.1B | +163% |
| Q1 2026 | $953M | +341% |
| Q4 2025 | $607M | +305% |
| Q3 2025 | $427M | +1481% |
| Q2 2025 | $425M | +12% |
| Q1 2025 | $216M | +69% |
| Q4 2024 | $150M | +52% |
STX has the edge over AVGO on cash flow, with stronger typical year-over-year growth.
AVGO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.9x | Healthy |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 4.1x | High |
AVGO's net debt is less than a year of its operating earnings (EBITDA), down from 2.3 years a year ago.
STX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.8x | Moderate |
STX has the edge over AVGO on leverage, with a lower net debt burden relative to earnings.
AVGO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 20.3 | Neutral |
AVGO's weekly RSI is 51 (neutral) and its Stochastic is 20 (neutral).
STX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 8.3 | Oversold |
STX's weekly RSI is 40 (neutral) and its Stochastic is 8 (oversold).
AVGO PE vs Technology Sector
| Metric | AVGO | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 28x | 67% above |
| PE % | 47 | 35 | 12 pts above |
AVGO is trading at 46x earnings, a 67% premium to the Technology sector's median of 28x.
STX PE vs Technology Sector
| Metric | STX | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 28x | 2.7% above |
| PE % | 75 | 35 | 40 pts above |
STX has the edge over AVGO on valuation relative to its sector.
AVGO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $338.0 | 7.8% above |
| 20 week MA | $362.1 | 0.6% above |
| 50 week MA | $363.0 | 0.4% above |
| 100 week MA | $313.8 | 16% above |
| 200 week MA | $214.3 | 70% above |
AVGO has the edge over STX on trend strength, trading above more of its moving averages.
STX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $683.6 | 20% below |
| 20 week MA | $785.0 | 31% below |
| 50 week MA | $630.7 | 14% below |
| 100 week MA | $387.3 | 41% above |
| 200 week MA | $234.4 | 133% above |
STX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 133% above its 200-week average.
AVGO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.7 | $43.2 | +36% |
| 2021 | $43.2 | $66.5 | +54% |
| 2022 | $66.5 | $55.2 | -17% |
| 2023 | $55.2 | $111.6 | +102% |
| 2024 | $111.6 | $241.8 | +117% |
| 2025 | $241.8 | $352.1 | +46% |
| 2026 YTD | $352.1 | $364.4 | +3.5% |
AVGO has finished higher in five of the last six years, three of them by more than 50%. It's up 3.5% so far in 2026.
STX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.6 | $63.0 | +5.7% |
| 2021 | $63.0 | $111.4 | +77% |
| 2022 | $111.4 | $50.5 | -55% |
| 2023 | $50.5 | $85.4 | +69% |
| 2024 | $85.4 | $87.4 | +2.4% |
| 2025 | $87.4 | $286.2 | +228% |
| 2026 YTD | $286.2 | $545.1 | +90% |
STX has the edge over AVGO on returns for 2026, with the stronger performance.